Most research on immunity to the SARS-CoV-2 virus and COVID-19 vaccine development has focused on antibody responses to the spike protein and other viral surface proteins. But antibodies that ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...

In this interview, News-Medical talks to Sylvia Xie, product scientist at Sino Biological, about the ongoing emergence of transmembrane proteins as targets for therapeutic antibodies. What is the ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma, biotech, and industrial biology. Ainnocence is expanding partnerships, ...

Antibody arrays: removal of high abundance proteins is not required, but antibody availability limits protein detection. Mass spectrometry: “hypothesis-free” protein detection is affected by high ...

University of Illinois students created oPool+, a breakthrough method to mass-produce and test thousands of antibodies.

Small, unique antibody-like proteins known as VNARs -- derived from the immune systems of sharks -- can prevent the virus that causes COVID-19, its variants, and related coronaviruses from infecting ...

COVID-19 is once again surging throughout the U.S., but deaths from the disease don’t seem to be following suit. That’s partly because many people have some level of immunity from vaccination or ...